Objective. The aim of the study was to investigate ex-vivo the bone marrow
(BM) stroma of mice under conditions of low- and high-dose cytosine arabino
side (Ara-C), a cycle-specific drug (S-phase) and to assess possible stroma
l damage, apart from the killing of hematopoietic cells. Stroma consists of
mesenchymal elements generally not in the cell cycle; therefore it. could
not be a target for the killing effect of Ara- C. Materials and Methods. Th
e stromal function was studied by tile following: the incidence of stromal
stem cells, i.e. CFU-F; formation of stromal layers under growth conditions
of long-term culture (LTC) followed by irradiation and overlayering of tes
t cells in contact and noncontact co-cultures; subsequent culture of the te
st cells in a semi-solid medium to assay the incidence of hyperproliferativ
e potential cells (HPPC); production of GM-CSF, IL-3, IL-4, IL-6 and IFN ga
mma in the conditioned medium (CM) of confluent stromal layers. All tests a
nd assays were carried out on BM specimens, 1-4 d after Ara-C administratio
n and on controls. Results. Low-dose Ara-C induces a marked decrease of CFU
-F, compensated by cycle induction of pre-CFU-F, young-type stromal stem ce
lls. High-dose Ara-C causes a CFU-F decrease to almost zero level. The time
length to layer confluency is normal after low-dose Ara-C (similar to 10 d
) and prolonged after a high dose (similar to 30 d). The confluent layers f
rom mice receiving low- or high-dose Ara-C support hematopoiesis adequately
. Among the growth factors and: cytokines assayed, only IL-6 is detected in
CM layers. IL-6 decreases after a low dose of Ara-C and increases after a
high dose. The cause of IL-6 fluctuations is yet to be investigated. It is,
however, evident that IL-6 is not an essential factor in support of hemato
poiesis. Conclusions. Taken together, the current study in mice indicates t
hat Ara-C administration, in particular a high dose, induces bone marrow st
romal damage and/or disfunction. The long period of time to roach layer con
fluency after a high Ara-C dose might reflect the in-vivo situation of slow
stromal regeneration.